WITHDRAWN: Characterization of Patterns of Immune Cell Infiltration in NSCLC.


Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235

Informations de publication

Date de publication:
04 Feb 2020
Historique:
received: 13 07 2019
revised: 19 12 2019
accepted: 22 12 2019
pubmed: 7 2 2020
medline: 7 2 2020
entrez: 7 2 2020
Statut: aheadofprint

Résumé

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

Identifiants

pubmed: 32028050
pii: S1556-0864(20)30015-0
doi: 10.1016/j.jtho.2019.12.127
pii:
doi:

Types de publication

Retraction of Publication

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020.

Auteurs

Max Backman (M)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Linnéa La Fleur (L)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Pinja Kurppa (P)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Dijana Djureinovic (D)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Hedvig Elfving (H)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Hans Brunnström (H)

Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.

Johanna S M Mattsson (JSM)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Victor Pontén (V)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Mohamed Eltahir (M)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Department of Pharmaceutical Bioscience, Uppsala University, Uppsala, Sweden.

Sara Mangsbo (S)

Department of Pharmaceutical Bioscience, Uppsala University, Uppsala, Sweden.

Johan Isaksson (J)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Department of Respiratory Medicine, Gävle Hospital, Gävle, Sweden.

Karin Jirström (K)

Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.

Klas Kärre (K)

Department of Microbiology, Cell and Tumor Biology, Karolinska Institute, Stockholm, Sweden.

Ennio Carbone (E)

Department of Microbiology, Cell and Tumor Biology, Karolinska Institute, Stockholm, Sweden; Department of Experimental and Clinical Medicine, Tumor Immunology and Immunopathology Laboratory, University Magna Graecia of Catanzaro, Catanzaro, Italy.

Karin Leandersson (K)

Department of Translational Medicine, Cancer Immunology, Lund University, Skåne University Hospital, Malmö, Sweden.

Artur Mezheyeuski (A)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Fredrik Pontén (F)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Cecilia Lindskog (C)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Johan Botling (J)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Patrick Micke (P)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Classifications MeSH